Prostate cancer is usually investigated by means of PSA. However, it is not usualy high specific and selective in early stage.
ISB toghether with Multimedica IRCCS reserch and clinical institute have published a test, based on mass spectrometry, for the prostate cancer dignosis. The test is based on relative ratio monitoring of a steroids pannel.
The test description has been published on the International scientific Journal named “Frontiers in Endocrinology” under Open Source licence. Download it here.